La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Eargo Résultats passés
Passé contrôle des critères 0/6
Eargo's earnings have been declining at an average annual rate of -35.8%, while the Medical Equipment industry saw earnings growing at 10.9% annually. Revenues have been declining at an average rate of 2.6% per year.
Informations clés
-35.8%
Taux de croissance des bénéfices
83.6%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 8.9% |
| Taux de croissance des recettes | -2.6% |
| Rendement des fonds propres | -239.7% |
| Marge nette | -263.1% |
| Dernière mise à jour des bénéfices | 30 Sep 2023 |
Mises à jour récentes des performances passées
Recent updates
Eargo: Straining To Be Heard
Aug 30Eargo jumps 77% following FDA rule on OTC hearing aids
Aug 16Eargo Non-GAAP EPS of -$0.78 misses by $0.55, revenue of $7.25M misses by $21.05M
Aug 08Eargo completes $100M senior secured convertible notes issuance
Jul 05Eargo: A Binary Play On Hearing Loss
Dec 30Eargo Is A High Risk 'Option' With High Potential
Oct 08An Intrinsic Calculation For Eargo, Inc. (NASDAQ:EAR) Suggests It's 23% Undervalued
Jul 10
Eargo: I Am Slowly Starting To Listen
May 06What Kind Of Investors Own Most Of Eargo, Inc. (NASDAQ:EAR)?
Jan 16Eargo trades high afte hours on strong Q4 revenue, gross systems shipped
Jan 11Eargo: A Word Of Caution
Dec 15Eargo beats on revenue
Nov 19Ventilation des recettes et des dépenses
Comment Eargo gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 23 | 41 | -108 | 88 | 19 |
| 30 Jun 23 | 41 | -141 | 94 | 19 |
| 31 Mar 23 | 40 | -149 | 102 | 18 |
| 31 Dec 22 | 37 | -157 | 107 | 19 |
| 30 Sep 22 | 34 | -159 | 121 | 23 |
| 30 Jun 22 | 4 | -188 | 139 | 25 |
| 31 Mar 22 | 19 | -175 | 140 | 26 |
| 31 Dec 21 | 32 | -158 | 136 | 25 |
| 30 Sep 21 | 44 | -124 | 118 | 21 |
| 30 Jun 21 | 85 | -45 | 94 | 17 |
| 31 Mar 21 | 79 | -32 | 78 | 14 |
| 31 Dec 20 | 69 | -30 | 70 | 12 |
| 30 Sep 20 | 57 | -32 | 63 | 12 |
| 30 Jun 20 | 47 | -44 | 59 | 12 |
| 31 Mar 20 | 38 | -47 | 55 | 13 |
| 31 Dec 19 | 33 | -44 | 48 | 13 |
| 30 Sep 19 | 30 | -42 | 45 | 12 |
| 31 Dec 18 | 23 | -34 | 34 | 10 |
| 31 Dec 17 | 7 | -25 | 15 | 5 |
Des revenus de qualité: EAR is currently unprofitable.
Augmentation de la marge bénéficiaire: EAR is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: EAR is unprofitable, and losses have increased over the past 5 years at a rate of 35.8% per year.
Accélération de la croissance: Unable to compare EAR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: EAR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.7%).
Rendement des fonds propres
ROE élevé: EAR has a negative Return on Equity (-239.7%), as it is currently unprofitable.